Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T MacLaughlin

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cellsJ H Kim, M M Seibel, D T MacLaughlin, et al.
Nature Neuroscience|July 21, 2000
A time-less function for mouse timelessA L Gotter, T Manganaro, D R Weaver, et al.
Human Reproduction (Oxford, England)|August 27, 2005
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphologyT Silberstein, D T MacLaughlin, I Shai, et al.
The New England Journal of Medicine|May 22, 1997
Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonadsM M Lee, P K Donahoe, B L Silverman, et al.
The Journal of Biological Chemistry|June 30, 2000
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathwayD L Segev, T U Ha, T T Tran, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen contentD B Seifer, D T MacLaughlin, A S Penzias, et al.
Endocrinology|May 26, 1999
Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cellsM M Lee, C C Seah, P T Masiakos, et al.
Recent Progress in Hormone Research|January 1, 1987
Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressorP K Donahoe, R L Cate, D T MacLaughlin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Mullerian inhibiting substance in humans: normal levels from infancy to adulthoodM M Lee, P K Donahoe, T Hasegawa, et al.
Endocrinology|January 1, 1996
Developmental expression of a candidate müllerian inhibiting substance type II receptorJ Teixeira, W W He, P C Shah, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cellsJ H Kim, M M Seibel, D T MacLaughlin, et al.
Nature Neuroscience|July 21, 2000
A time-less function for mouse timelessA L Gotter, T Manganaro, D R Weaver, et al.
Human Reproduction (Oxford, England)|August 27, 2005
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphologyT Silberstein, D T MacLaughlin, I Shai, et al.
The New England Journal of Medicine|May 22, 1997
Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonadsM M Lee, P K Donahoe, B L Silverman, et al.
The Journal of Biological Chemistry|June 30, 2000
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathwayD L Segev, T U Ha, T T Tran, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen contentD B Seifer, D T MacLaughlin, A S Penzias, et al.
Endocrinology|May 26, 1999
Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cellsM M Lee, C C Seah, P T Masiakos, et al.
Recent Progress in Hormone Research|January 1, 1987
Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressorP K Donahoe, R L Cate, D T MacLaughlin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Mullerian inhibiting substance in humans: normal levels from infancy to adulthoodM M Lee, P K Donahoe, T Hasegawa, et al.
Endocrinology|January 1, 1996
Developmental expression of a candidate müllerian inhibiting substance type II receptorJ Teixeira, W W He, P C Shah, et al.
Pageof 8